Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Contraceptive use may be safe, but information gaps remain

Contraceptive use may be safe, but information gaps remain

January 14, 2009

Introduced in the 1960s, oral contraceptives have been used by about 80 percent of women in the United States at some point in their lives. For women without pre-existing risks for heart disease, the early formulations were generally safe, and the newer ones appear to be even safer, but all the risks and benefits are yet to be established, especially as women's lifestyles change and new forms of contraceptives become available, according to specialists in women's heart disease at Cedars-Sinai Medical Center.

"As women use these therapies more frequently and for longer periods of time, there is an urgent need to better understand and minimize associated cardiovascular risks," said C. Noel Bairey Merz, M.D., director of the Women's Heart Center and the Preventive and Rehabilitative Cardiac Center at the Cedars-Sinai Heart Institute. She is senior author of an article in the Jan. 20, 2009, issue of the Journal of the American College of Cardiology that provides an overview of the known cardiovascular risks and benefits of hormonal contraceptives while pointing out areas that require further research.




Reproductive hormones affect the tone and function of blood vessels as well as lipid (fat) levels in the blood. Low estrogen levels have been found to increase risk of coronary atherosclerosis (thickening and hardening of artery walls) and "adverse cardiac events," such as heart attacks and strokes. But the use of supplemental estrogen in hormone replacement therapy has been linked to an elevated risk of blood clots that can lead to heart attacks and strokes.

"Health care providers must evaluate each woman's risk factors, especially those related to cardiovascular health, prior to starting any contraceptive therapy. Although pre-menopausal women have a much lower risk of cardiovascular disease, routine screening for potential problems and follow-up is important," said Chrisandra L. Shufelt, M.D., assistant director of the Women's Heart Center at the Cedars-Sinai Heart Institute and co-author of the journal article.

The earlier contraceptives used higher levels of estrogen than the newer formulations, which are now available not only in pill form but in patches and vaginal rings. The newer formulations use lower doses of estrogen, which is safer in terms of lowering the risk of blood clots, and they tend to use a progestin, a synthetic version of progesterone that is not likely to raise blood pressure and may even slightly reduce it, according to Bairey Merz, who holds the Women's Guild Endowed Chair in Women's Health and is a professor of medicine at Cedars-Sinai.

Since 2000, death rates have increased in women between the ages of 35 and 44, while all other age groups have seen a decline. Among factors that may be contributing to the rise are increases in obesity and smoking, a decline in physical activity at this time in life, and a significant increase in the use of oral contraceptives.

Women at high risk for cardiovascular problems, especially those who smoke, should consider alternative forms of contraception. Those with other cardiac risk factors, such as hypertension or elevated cholesterol, can consider using hormonal contraceptives if they are carefully monitored by their health care provider, Bairey Merz said.

Any woman considering the use of contraceptives should be evaluated for cholesterol levels, blood pressure, smoking, diabetes, kidney problems, obesity and other vascular diseases, including migraines. Healthy, nonsmoking women who are 35 or older can continue taking a low dose oral contraceptive until 50 to 55 years after reviewing the risks and benefits.

Cedars-Sinai Medical Center



Related Contraceptives Current Events and Contraceptives News Articles Contraceptives Current Events and Contraceptives News RSS Contraceptives Current Events and Contraceptives News RSS
AIDS research reveals a lack of family-planning programs in Uganda
University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception.

Worksite wellness programs may reduce employee absenteeism
Emory University Rollins School of Public Health researchers will present Nov. 11 on a range of topics at the American Public Health Association's annual meeting in Philadelphia, including a study that found reduced absenteeism among employees participating in a large-scale worksite wellness program.

Oral contraceptives may benefit women with asthma
New research shows that during natural menstrual cycles, women with asthma who were not taking oral contraceptives (OC) had lower exhaled nitric oxide levels (eNO), a marker of airway inflammation associated with asthma, than women who were taking OC.

The IUD is the most popular long-acting contraceptive amongst Europeans
A European study has defined the profile for the usage of long-acting contraceptive methods. The work, presented with the National Congress of Gynaecology award, shows, amongst other things, that 10% of women use these methods, the majority over 30 years old.

Research: Migraine and cardiovascular disease: Systematic review and meta-analysis
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today.

Increased stroke risk from birth control pills
She was only 30 years old, but she was experiencing the classic symptoms of a stroke. Her speech suddenly became slurred, and her left hand became clumsy while eating.

Pregnancy complications are a stress test for future maternal health and pregnancies
Predicting whether pregnancy complications affect long-term maternal health as well as future pregnancies is at the heart of two studies conducted by researchers in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine.

Study explains potential failure of oral contraceptives with obese women
Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.

2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.

Why dishing does you good: U-M study
Why does dishing with a girlfriend do wonders for a woman's mood?
More Contraceptives Current Events and Contraceptives News Articles
Ortho options vaginal contraceptive gel with applicators, unscented - 10

Ortho options vaginal contraceptive gel with applicators, unscented - 10
by J&J HEALTH CARE.

INDICATIONS: Ortho options vaginal contraceptive gel with applicators, unscented is used for the prevention of pregnancy. Apply not more than an hour before intercourse. For best protection against pregnancy.

Contraceptive Technology, 19th Edition

Contraceptive Technology, 19th Edition
by Robert A. Hatcher (Author), James Trussell (Author), Anita L. Nelson (Author), Willard Cates Jr. (Author), Felicia Stewart (Author)

New scientific and medical developments in reproductive health have emerged in the past 5 years. This latest edition of Contraceptive Technology focuses on the benefits of a variety of safe and effective contraceptive methods, enabling physicians to counsel their patients on some of the most important decisions that will shape their lives.

Edited for ob/gyns, reproductive medicine MDs, gynecologists and primary care physicians specializing in women's health, the 19th edition of Contraceptive Technology continues to provide recommendations that will ensure that every pregnancy is intended and as safe as possible.

This edition refers to the soft cover version of this title.

Vaginal Contraceptive Film - 28% Nonoxynol-9: 12 units.

Vaginal Contraceptive Film - 28% Nonoxynol-9: 12 units.
by VCF

VCF Vaginal Contraceptive Film is a translucent 2 inch by 2 inch insert Begins to dissolve instantly No hormonal side effects Kills sperm on contact Sexually enhancing Lasts up to 3 hours Contains the spermicide doctors recommend most, Nonoxynol-9 NOTE: this product is hand packed VCF is a translucent square of material containing the active ingredient Nonoxynol-9, a wisely used, highly efficient spermicide. Placed high in the vagina, as close as possible to the neck of the womb (cervix), it dissolves into a gel which exerts a powerful contraceptive effect against sperm. It is a potent spermicidal agent used successfully by millions of women. Because VCF is small and unnoticed in use, it can be used discreetly by the woman. It does not run and will not stain. VCF is eventually washed...

Vaginal Contraceptive Inserts

Vaginal Contraceptive Inserts
by Encare

Encare vaginal contraceptive inserts are the birth control women can trust! Encare Vaginal Contraceptive Inserts for the prevention of pregnancy No hormonal side effects Kills sperm on contact and dispenses a physical barrier of protection against the cervix Individually wrapped Convenient to carry Contains the spermicide doctors recommend most, Nonoxynol-9 *This product is not effective against HIV, AIDS, or other sexually transmitted diseases.

  Managing Contraceptive Pill Patients
by Richard P. Dickey (Author)

Louisiana State Univ., New Orleans. Contains most of the known oral contraceptive (OC) side effects and their causes with a recommended plan of management. Tables list categorical activities of OCs. Intended to help clinicians choose among OC types. Trim size: 7.5 x 4.25 inches. Softcover.

Today Sponge

Today Sponge
by Mayer Laboratories



Devices and Desires: A History of Contraceptives in America

Devices and Desires: A History of Contraceptives in America
by Andrea Tone (Author)

From thriving black market to big business, the commercialization of birth control in the United States

In Devices and Desires, Andrea Tone breaks new ground by showing what it was really like to buy, produce, and use contraceptives during a century of profound social and technological change. A down-and-out sausage-casing worker by day who turned surplus animal intestines into a million-dollar condom enterprise at night; inventors who fashioned cervical caps out of watch springs; and a mother of six who kissed photographs of the inventor of the Pill -- these are just a few of the individuals who make up this riveting story.


New & Improved TODAY Sponge Vaginal Contraceptive (TEAL BLUE BOX) Sponge 3 Pack EXP FEB 2011

New & Improved TODAY Sponge Vaginal Contraceptive (TEAL BLUE BOX) Sponge 3 Pack EXP FEB 2011
by Mayer Laboratories, INc.

Today Sponge is a soft polyurethane foam sponge containing nonoxynol 9, a spermicide used by millions of women for more that 20 years in other forms of intravaginal drug products. Today Sponge has a unique 3-way action which provides safe and effective protection without hormones. From the makers of Kimono CONDOMS.

Tarascon Rapid Reference Card: Contraceptive Methods

Tarascon Rapid Reference Card: Contraceptive Methods
by MD Dr. Joseph Esherick (Author)

Measuring only 5.5 x 3.25 inches, this quick and handy laminated card tucks neatly into your Tarascon books to provide you with immediate access to the most frequently used tables in your Tarascon Pharmacopoeia or Pocketbook.

Vaginal Contraceptive Foam - 12.5%

Vaginal Contraceptive Foam - 12.5%
by VCF

VCF Vaginal Contraceptive Foam is a white, lightly scented, non-staining foam Laboratory tested contraceptive works instantly Applicator included Net Wt. 0.6 oz. VCF Vaginal Contraceptive Foam is a white, lightly scented, non-staining foam. VCF is tested by independent laboratories for determination of sperm inactivating qualities, using the I.P.P.F. agreed protocol. VCF foam is effective immediately, and is easy to use. VCF contains the spermicide most recommended by doctors, nonoxynol-9. *This product is not effective against HIV, AIDS, or other sexually transmitted diseases.

© 2009 BrightSurf.com